Skip to main content
OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
4.018
-0.042 (-1.03%)
At close: Mar 6, 2026

OSE Immunotherapeutics Revenue

In the year 2025, OSE Immunotherapeutics had annual revenue of 1.78M EUR, down -97.86%. OSE Immunotherapeutics had revenue of 862.00K in the half year ending December 31, 2024, a decrease of -61.77%.

Revenue
1.78M
Revenue Growth
-95.84%
P/S Ratio
50.55
Revenue / Employee
27.84K
Employees
64
Market Cap
90.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.78M-81.65M-97.86%
Dec 31, 202483.44M81.21M3,646.52%
Dec 31, 20232.23M-16.08M-87.83%
Dec 31, 202218.30M-8.00M-30.43%
Dec 31, 202126.31M15.89M152.48%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sensorion 5.65M
ABIONYX Pharma 4.33M
Adocia 12.88M
Valerio Therapeutics Société anonyme 1.83M
MaaT Pharma 3.92M
Innate Pharma 12.64M
THX Pharma Société Anonyme 876.13K
Nicox 3.32M
Revenue Rankings

OSE Immunotherapeutics News

More News